| |||||||||||||||||||||||||||||||||||
Study ID | Study | Experiment Name | Experiment Notes | Strain Ont ID | Strain | Sex | Age | # of Animals | Sample Notes | Clinical Measurement Ont ID | Phenotype | Formula | Clinical Measurement Notes | Average Type | Value | Units | SEM | SD | Method Ont ID | Method | Method Site | Method Duration | Method Notes | Post Insult Type | Post Insult Time Value | Post Insult Time Unit | Conditions | Record ID | |||||||
1161 | Holm BC, et al., Hum Mol Genet 2001 Mar 15;10(6):565-72. | joint integrity trait | RS:0000495 | LEW.1AV1.DA-(D10Rat92-D10Wox17)/Ubc | male | 0 days | 6 | CMO:0001453 | percentage of study population developing experimental arthritis during a period of time | 33 | % | MMO:0000163 | in vivo visual assessment | 0.0 | squalene (860 mg/ml) | 69643 | squalene (860 mg/ml) | ||||||||||||||||||
1161 | Holm BC, et al., Hum Mol Genet 2001 Mar 15;10(6):565-72. | joint integrity trait | RS:0000495 | LEW.1AV1.DA-(D10Rat92-D10Wox17)/Ubc | female | 0 days | 17 | CMO:0001453 | percentage of study population developing experimental arthritis during a period of time | 29 | % | MMO:0000163 | in vivo visual assessment | 0.0 | squalene (860 mg/ml) | 69642 | squalene (860 mg/ml) | ||||||||||||||||||
1161 | Holm BC, et al., Hum Mol Genet 2001 Mar 15;10(6):565-72. | joint integrity trait | RS:0000495 | LEW.1AV1.DA-(D10Rat92-D10Wox17)/Ubc | male | 0 days | 6 | CMO:0001450 | post-insult time to onset of experimental arthritis | median | 22 | d | MMO:0000163 | in vivo visual assessment | 0.0 | squalene (860 mg/ml) | 69649 | squalene (860 mg/ml) | |||||||||||||||||
1161 | Holm BC, et al., Hum Mol Genet 2001 Mar 15;10(6):565-72. | joint integrity trait | RS:0000495 | LEW.1AV1.DA-(D10Rat92-D10Wox17)/Ubc | female | 0 days | 17 | CMO:0001450 | post-insult time to onset of experimental arthritis | median | 24 | d | MMO:0000163 | in vivo visual assessment | 0.0 | squalene (860 mg/ml) | 69648 | squalene (860 mg/ml) |